WILLIAM SHARFMAN, M.D.
Medical Oncology Physician · LUTHERVILLE, MD
Individual Active NPI 1760413652
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 558 | 326,675 | $37,625,769 | $14,537,580 | $11,573,816 |
| 2023 | 518 | 295,242 | $35,417,885 | $13,070,500 | $10,405,025 |
| 2022 | 594 | 215,569 | $21,918,616 | $7,942,399 | $6,329,273 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 61,760 | $28 | $22 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 45,540 | $49 | $39 |
| J9271 | Injection, pembrolizumab, 1 mg | 39,600 | $56 | $45 |
| J9298 | Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg | 24,480 | $154 | $123 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 17,980 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,500 | $0 | $0 |
| J9228 | Injection, ipilimumab, 1 mg | 8,325 | $160 | $127 |
| J9171 | Injection, docetaxel, 1 mg | 4,824 | $1 | $1 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,040 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,998 | $0 | $0 |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 959 | $3 | $3 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 956 | $137 | $107 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | D38409 | MD |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Maryland
- NPI 1861420291
- NPI 1720016777
- NPI 1437113255
- NPI 1598470551
- NPI 1013947126
- NPI 1689609075
- NPI 1780631713
- NPI 1427497551
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.